Shares of Genmab A/S (OTCMKTS:GNMSF - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $211.31 and traded as low as $190.50. Genmab A/S shares last traded at $190.50, with a volume of 22 shares trading hands.
Genmab A/S Trading Up 4.4 %
The firm has a 50 day moving average price of $203.93 and a 200 day moving average price of $210.35. The stock has a market capitalization of $13.25 billion, a PE ratio of 11.45 and a beta of 1.10.
Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $5.70 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $5.24. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%.
About Genmab A/S
(
Get Free Report)
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.
Featured Articles
Before you consider Genmab A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genmab A/S wasn't on the list.
While Genmab A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.